Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Cancer Drug Targets|December 11, 2012
The PI3 kinase signaling pathway in prostate cancerAymen A Elfiky, Zhenyang JiangDiscovery Medicine|June 30, 2012
Novel molecular targets for the therapy of renal cell carcinomaAymen A Elfiky, Guru SonpavdeCurrent Oncology Reports|April 2, 2009
Targeting angiogenesis in bladder cancerAymen A Elfiky, Jonathan E RosenbergExpert Opinion on Biological Therapy|June 9, 2007
The developing trend of monoclonal antibodies in the treatment of colorectal cancerAymen A Elfiky, Muhammad W SaifDiscovery Medicine|February 21, 2016
Assessment and management of advanced adrenocortical carcinoma using a precision oncology care modelAymen A Elfiky, Hari K Krishnan NairTherapeutic Advances in Medical Oncology|July 27, 2011
Novel agents for advanced bladder cancerGuru Sonpavde, Aymen A Elfiky, Jonathan E RosenbergJAMA Network Open|January 16, 2019
Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting ChemotherapyAymen A Elfiky, Maximilian J Pany, Ravi B Parikh, et al.JCO Clinical Cancer Informatics|January 18, 2019
Applied Informatics Decision Support Tool for Mortality Predictions in Patients With CancerDimitris Bertsimas, Jack Dunn, Colin Pawlowski, et al.Journal of Translational Medicine|August 13, 2011
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancerAymen A Elfiky, Saadia A Aziz, Patricia J Conrad, et al.Urologic Oncology|May 11, 2010
Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinomaAymen A Elfiky, Daniel C Cho, David F McDermott, et al.Pageof 2